Miebo Patient Assistance Program

(perfluorohexyloctane ophthalmic solution)

Key Takeaways

  1. Miebo® (perfluorohexyloctane ophthalmic solution) is a prescription eye drop approved for the treatment of the signs and symptoms of dry eye disease.
  2. Miebo is the first FDA-approved prescription medication specifically designed to reduce tear evaporation, helping stabilize the lipid layer of the tear film.
  3. Miebo does not carry an FDA Boxed Warning and works through a physical mechanism rather than by suppressing inflammation.
  4. Prescription Hope may help eligible individuals access manufacturer-sponsored patient assistance programs that can make Miebo more affordable.

 

Introduction

Dry eye disease is a common condition that occurs when the eyes do not produce enough tears or when tears evaporate too quickly. This can lead to symptoms such as irritation, discomfort, blurred vision, and a feeling of dryness that may interfere with daily activities.

Miebo is a prescription ophthalmic medication designed to reduce tear evaporation by stabilizing the lipid layer of the tear film. Unlike many traditional artificial tears, Miebo is water-free and specifically targets evaporative dry eye, including many patients with meibomian gland dysfunction.

Because Miebo is a brand-name prescription medication, treatment costs may vary depending on insurance coverage and pharmacy pricing. Many people searching for a Miebo patient assistance program are looking for ways to reduce their prescription expenses. Prescription Hope may help eligible patients obtain Miebo at a more affordable cost through patient assistance programs.

What Is the Miebo Patient Assistance Program?

Understanding Miebo Prescription Assistance

Pharmaceutical manufacturers recognize the financial burden that some brand-name medications can cause struggling Americas, so they have come up with a solution called patient assistance programs. These programs, such as the Miebo patient assistance program, allow qualified patients access to name-brand medications at a fraction of the retail cost.

Unfortunately, patient assistance programs have a reputation for being difficult and complex to navigate. However, Prescription Hope can help.

How Expert Advocates Help Make Miebo More Affordable

Personalized Medication Assistance

Prescription Hope offers patient support services throughout the process of applying to a patient assistance program and even after acceptance into the program. That means that qualified patients can get Miebo enrollment assistance through Prescription Hope.

Our patient support services through the application process include form completion, document and signature collection, coordinating with healthcare providers and manufacturers, dispute advocacy and support, and more.

Ongoing Patient Support

Prescription Hope is ready to help you both with your application into a patient assistance program and with long-term medication assistance for as long as you are a patient with us. Some of the administrative tasks our team can assist with during your treatment continuity include refill scheduling, document updates, yearly renewals, program monitoring, and more.

Miebo Price Comparison

vs

Prescription Hope logo

Estimated Retail Price*

$1,352.47

30-Day Supply

Prescription Hope Price

$70

Per Month, NO Matter The Retail Price

*Source: Drugs.com

Navigating Dry Eye Treatment Costs

There are many ways to help patients save money on the name-brand medication they need, but there are often drawbacks to each one. Insurance can include high co-pays or deductibles, discount cards and coupons have a cap for how much they can help you save, and government programs can include large gaps.

Prescription Hope is not a coupon card, government-affiliated, or an insurance policy. We are a service that helps qualified patients gain access to the medication they need for the low price of $70.00 per month, per medication. We do not charge you for medication costs, hidden fees, or add-ons.

Even if you are unable to qualify for the name-brand medication you need, we will work hard to help you find other ways to save like substitute medications, discount cards, coupons, or other ways to save.

Miebo Patient Assistance Eligibility

General Eligibility Requirements

Prescription assistance eligibility is different for each patient assistance program. Prescription Hope can help a patient determine who qualifies for Miebo assistance. However, all programs keep criteria in several general categories, some of which include:

Income: All programs have their own requirements for what a qualified patient’s income status needs to be.

Insurance: All programs also have their own requirements for what a qualified patient’s insurance coverage status needs to be.

Prescription: In order to qualify, patients must have a valid prescription for the name-brand medication they need.

U.S. Residency: Only U.S. residents can qualify for patient assistance programs.

Simple Enrollment With Expert Support

Getting Started With Enrollment

Are you curious about the Miebo application process? Do you want to enroll in Miebo assistance? Apply for Prescription Hope’s prescription support services in 6 easy steps:

  1. Submit Information: Take a few minutes to fill out our online enrollment form.
  2. Advocate Contact: A patient advocate will reach out to you within 1-2 business days after receiving your application.
  3. Document Collection: Our team will collect any needed documents after your prequalification.
  4. Provider Coordination: Our team will also coordinate with your healthcare providers to get any vital signatures.
  5. Program Submission: After everything is in order, our team will submit your application to a patient assistance program on your behalf, continuing to keep in touch with the pharmaceutical manufacturer.
  6. Medication Delivery: Patients will typically receive their medication in the mail after 2 weeks once their application is approved. All medication is shipped directly from the manufacturer to the patient’s door or doctor’s office.

Understanding Miebo

How Miebo Works

Miebo contains perfluorohexyloctane, a semifluorinated alkane.

After instillation into the eye, perfluorohexyloctane spreads across the ocular surface, forming a layer over the tear film that helps reduce tear evaporation and stabilize the lipid layer. By decreasing evaporative tear loss, Miebo helps relieve the signs and symptoms associated with dry eye disease.

Unlike anti-inflammatory dry eye medications, Miebo works through a physical mechanism rather than by suppressing inflammation.

What Conditions Does Miebo Treat?

Miebo is indicated for the treatment of the signs and symptoms of dry eye disease.

Miebo is specifically designed to reduce tear evaporation associated with dry eye disease by stabilizing the lipid layer of the tear film. Unlike many traditional artificial tears, Miebo is water-free and targets evaporative dry eye.

Benefits of Treatment

For appropriate patients with dry eye disease, Miebo may:

  • Reduce tear evaporation
  • Improve symptoms of dry eye disease
  • Help stabilize the tear film lipid layer
  • Improve ocular surface comfort
  • Provide a preservative-free, water-free treatment option
  • Target evaporative dry eye, including many patients with meibomian gland dysfunction

Individual treatment response varies, and continued use may be necessary to maintain symptom improvement.

Important Safety Information and Side Effects

Miebo does not carry an FDA Boxed Warning.

Contraindications

The FDA Prescribing Information lists no contraindications for Miebo.

The most commonly reported adverse reactions include:

  • Blurred vision
  • Eye redness (ocular hyperemia)
  • Eye irritation

These adverse reactions were generally mild in clinical trials.

Patients should notify their healthcare provider if side effects become severe, persistent, or worsen over time.

Patients should discuss the following with their healthcare provider:

  • Miebo is for topical ophthalmic use only.
  • Do not administer by injection.
  • Do not swallow the solution.
  • Remove contact lenses before administration and wait at least 30 minutes before reinserting them.
  • Avoid allowing the dropper tip to touch the eye, fingers, or other surfaces to reduce the risk of contamination.
  • Do not use the product if the seal is broken or if the solution appears contaminated.

The FDA Prescribing Information does not include additional major safety warnings or precautions beyond proper administration instructions.

Available human data are insufficient to determine whether Miebo poses a drug-associated risk during pregnancy. Systemic exposure following topical ophthalmic administration is negligible, and clinically significant fetal exposure is not expected.

It is not known whether perfluorohexyloctane is present in human milk. Because systemic absorption is negligible following topical administration, clinically significant exposure to a breastfed infant is not expected. Patients should discuss breastfeeding with their healthcare provider.

No clinically significant drug interactions are described in the FDA Prescribing Information. If more than one topical ophthalmic medication is used, the medications should be administered at least 5 minutes apart, or patients should follow their healthcare provider’s instructions regarding administration timing.

Miebo is administered by placing one drop into each affected eye four times daily. It is intended for topical ophthalmic use only. Patients should wash their hands before use, remove contact lenses before administration, and wait at least 30 minutes before reinserting contact lenses. To help prevent contamination, the dropper tip should not touch the eye or surrounding surfaces. Miebo should always be used exactly as prescribed by a healthcare provider.

Access to Multiple Medications

Support Beyond Miebo

People looking for eye medication assistance sometimes need multiple medication assistance programs due to their ongoing need for ophthalmic prescription support. Prescription Hope offers the same prescription access services for hundreds of name-brand medications, which means that every medication you qualify for can be accessed through Prescription Hope for the same service fee of $70.00 per month, per medication.

Why Choose Prescription Hope

Patient-Focused Medication Support

Since 2006, Prescription Hope has given patient-centered prescription help and prescription affordability support to qualified patients all over America, from the big cities to the rural areas. We are proud to say that we offer Miebo assistance through Prescription Hope.

Simplified Access to Prescription Medications

Patient assistance services through Prescription Hope are available to qualified patients at a low cost of $70.00 per month, per medication with no add-ons, hidden charges, or medication costs. If Prescription Hope cannot find a way to help you save money, you owe us nothing.

Ongoing Prescription Assistance

We don’t just offer solutions for your prescription affordability programs. Prescription Hope is here to help with all your needs related to long-term medication support, such as refill scheduling, yearly renewals, document updates, program monitoring, and more.

Network Access

Prescription Hope has access to a network that includes hundreds of brand-name medications and their associated patient assistance programs.

If you need access to the Miebo Patient Assistance Program and you’re not sure where to start, enroll with Prescription Hope to see how we can help you save money today!

 

Frequently Asked Questions

It's Easy!

Submit Enrollment Form

Getting started is free and easy! Simply complete the online enrollment form. 

Receive Welcome Call

An Enrollment Specialist will reach out to you for a personalized welcome call.

We Manage The Process

Your dedicated team manages your account month after month, allowing you to focus on what matters most—your health.

Helpful Articles

Latest News & Stories

Save Money On Your Prescriptions Today!